Vitamin E Supplementation Decreases Autoantibodies to Oxidized Lipid-Protein Complexes

Journal of Medicinal Food

Volumn 1, Issue 4, 1998, Pages 247-251

  Santanam, Nalini ^a   Jonas, Carolyn ^a   Murphy, Ana A ^a   Parthasarathy, Sampath ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85008403359     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.1998.1.247     Document Type: Article

References (24)

1. Baila, J., Belcher, J. D., Baila, G., Jacob, H. S., and Vercellotti, G. M. (1993). Oxidized low-density lipoproteins and endothelium: Oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury. Trans Assoc Am Physicians 106, 128–133.
2. Bligh, E. G. and Dyer, W. J. (1959). Rapid method to total lipid extraction and purification. Can J Biochem Physiol 37, 911–917.
3. Carpenter, K. L., Taylor, S. E., Ballantine, J. A., Fussell, B., Halliwell, B., and Mitchinson, M. J. (1993). Lipids and oxidised lipids in human atheroma and normal aorta. Biochim Biophys Acta 1167, 121–130.
4. Cheeseman, K. H. and Emery, S. (1987). Effects of alpha-tocopherol on carbontetrachloride metabolism in rat liver microsomes. Free Radie Res Commun 3, 325–330.
5. Devaraj, S., Adams-Huet, B., Fuller, C. J., and Jialal, I. (1997). Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation. Arterioscler Thromb Vase Biol 17, 2273–2279.
6. Fruebis, J., Parthasarathy, S., and Steinberg, D. (1992). Evidence for a concerted reaction between lipid hydroperoxides and polypeptides. Proc Natl Acad Sci USA 89, 10588–10592.
7. Fuller, C. J., Huet, B. A., and Jialal, I. (1998). Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation. Am J Cardiol 81, 231–233.
8. Kim, J. G., Sabbagh, F., Santanam, N., Wilcox, J. N., Medford, R. M., and Parthasarathy, S. (1997). Generation of a polyclonal antibody against lipid peroxide-modified proteins. Free Radie Biol Med 23, 251–259.
9. Maggi, E. R., Chiesa, G., Melissano, R., Castellano, D., Astore, A., and Grossi, G. (1994). LDL oxidation in patients with severe carotid atherosclerosis: A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 14, 1892–1899.
10. Mallik, M., Santanam, N., and Parthasarathy, S. (1998). Oxidation of low density lipoprotein in plasma. In Oxygen Radicals and the Disease Process. C. E. Thomas and B. Kalyanaraman, eds. (Harwood Academic Publishers, Amsterdam, The Netherlands).
11. Markesbery, W. R. and Lovell, M. A. (1998). Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19, 33–36.
12. Mowri, H., Ohkuma, S., and Takano, T. (1988). Monoclonal DLRla/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions. Biochim Biophys Acta 963, 208–214.
13. Murphy, A. A., Palinski, W., Rankin, S., Morales, A. J., and Parthasarathy, S. (1998). Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil Steril 69, 1092–1094.
14. Murphy, A. A., Santanam, N., Morales, A. J., and Parthasarathy, S. (1998). Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes, is elevated in endometriosis. J Clin Endocrinol Metab 83, 2110–2113.
15. Owen, A. D., Schapira, A. H., Jenner, P., and Marsden, C. D. (1997). Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies [review]. J Neural Transm Suppl 51, 167–173.
16. Palinski, W., Yla-Herttuala, S., Rosenfeld, M. E., Butler, S. W., Socher, S. A., Parthasarathy, S., Curtiss, L. K., and Witztum, J. L. (1990). Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10, 325–335.
17. Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., and Witztum, J. L. (1994). ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 14, 605–616.
18. Palinski, W., Miller, E., and Witztum, J. L. (1995). Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 92, 821–825.
19. Palinski, W., Horkko, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., and Witztum, J. L. (1996). Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 98, 800–814.
20. Porkkala-Sarataho, E., Nyyssonen, K., and Salonen, J. T. (1996). Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men. Atherosclerosis 124, 83–94.
21. Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K., and Mitchinson, M. J. (1996). Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) [see comments]. Lancet 347, 781–786.
22. Virella, G. T., Munoz, J. F., Galbraith, G. M. P., Gissinger, C., Chassereau, C., Lopus-Virella, G. I., Virella, R. B., Leman, M. B., Pryor, M. F., and Lopus-Virella, M. (1993). Antioxidized low-density lipoprotein antibodies in patients with coronary artery disease and normal healthy volunteers. Int J Clin Lab Res 23, 95–101.
23. Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., and Steinberg, D. (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84, 1086–1095.
24. Yla-Herttuala, S., Palinski, W., Butler, S. W., Picard, S., Steinberg, D., and Witztum, J. L. (1994). Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14, 32–40.